Table 4 Usefulness and safety of transcystic drainage in patients with an intra-operative suspicion of common bile duct stone
Patients with transcystic drainage (N = 5) | Patients without transcystic drainage (N = 45) | P value | ||
|---|---|---|---|---|
Duodenal passage of contrast product during IOC | Difficult duodenal passage, No. | 2 (40%) | 4 (9%) | .04 |
No duodenal passage, No. | 3 (60%) | 4 (9%) | .002 | |
Delay between surgery and post-operative CBD assessment, days | 1 ± 0.4 | 2 ± 1.3 | .003 | |
Length of stay (mean ± SD), days | 11 ± 8 | 9 ± 4 | .56 | |
Length of transcystic drainage (mean ± SD), days | 39 ± 22 | 0 | ||
Complications (Dindo-Clavien classification) | Grade I, No. | 0 | 7 | .34 |
Grade II, No. | 0 | 3 | .55 | |
Grade III, No. | 0 | 4 | .49 | |
Grade IV, No. | 1 | 1 | .05 |